Clinical Trial Update: Optimized Erythropoietin (EPO) Treatment [Phase 2]

View source ↗

Summary

Phase 2 trial update on Optimized Erythropoietin (EPO) treatment in neonatal anemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Anemia

Drugs mentioned

• Optimized Erythropoietin (erythropoietin)

Snippet

Sponsor: John A Widness | Conditions: Neonatal Anemia | Phase 2 | Status: COMPLETED